Cargando…
SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
Developmental factors may regulate the expression of immune modulatory proteins in cancer, linking embryonic development and cancer cell immune evasion. This is particularly relevant in melanoma because immune checkpoint inhibitors are commonly used in the clinic. SRY-box transcription factor 10 (SO...
Autores principales: | Rosenbaum, Sheera R., Tiago, Manoela, Caksa, Signe, Capparelli, Claudia, Purwin, Timothy J., Kumar, Gaurav, Glasheen, McKenna, Pomante, Danielle, Kotas, Daniel, Chervoneva, Inna, Aplin, Andrew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720266/ https://www.ncbi.nlm.nih.gov/pubmed/34879275 http://dx.doi.org/10.1016/j.celrep.2021.110085 |
Ejemplares similares
-
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
por: Capparelli, Claudia, et al.
Publicado: (2022) -
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas
por: Purwin, Timothy J., et al.
Publicado: (2023) -
MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
por: Vu, Ha Linh, et al.
Publicado: (2015) -
CADM1 is a TWIST1-regulated suppressor of invasion and survival
por: Hartsough, Edward J., et al.
Publicado: (2019) -
The future of targeted kinase inhibitors in melanoma
por: Caksa, Signe, et al.
Publicado: (2022)